vimarsana.com
Home
Live Updates
Amyloid Diagnostic - Breaking News
Pages:
Latest Breaking News On - Amyloid diagnostic - Page 1 : vimarsana.com
Attralus to Present New Data on Its Amyloidosis Portfolio at the 2022 International Symposium on Amyloidosis
Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, today
Baden wüberg
San francisco
United states
Arnt kristen
Ashutosh wechalekar
Luke heagle
Christophe sirac
Alan stuckey
Manasi balachandran
Emily martin
Olivier clerc
J steve foster
Neue universit
R eric heidel
Gregory bell
Marina ramirez alvarado
Attralus to Present New Data on Its Amyloidosis Portfolio
SAN FRANCISCO, Aug. 22, 2022 (GLOBE NEWSWIRE) Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to.
Baden wüberg
Arnt kristen
Ashutosh wechalekar
Christophe sirac
Alan stuckey
Manasi balachandran
Emily martin
J steve foster
Olivier clerc
Neue universit
R eric heidel
Gregory bell
Marina ramirez alvarado
Morie gertz
International symposium on amyloidosis
University college london
Attralus Receives U S FDA Orphan Drug Designation for
SAN FRANCISCO, Aug. 08, 2022 (GLOBE NEWSWIRE) Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to.
United states
San francisco
Luke heagle
Gregory bell
Isabelle lousada
Attralus inc
International symposium on amyloidosis
University of tennessee medical center
University of tennessee research foundation
Amyloidosis research consortium
Drug administration
Chief medical officer
Tennessee medical center
Drug designation
Orphan drug designation
Amyloidosis research
vimarsana © 2020. All Rights Reserved.